Discover the latest research on Ozempic and other GLP-1 medications, including potential uses in treating Alzheimer's and opioid and alcohol use disorders.

Alzheimer’s causes a gradual decline in memory, thinking, behaviour, and social skills, and it is the most common cause of ...

Ozempic has quickly become a household name with medical researchers claiming the breakthrough drug can have many benefits.

Semaglutide outperformed 7 diabetes medications in reducing risk of Alzheimer's disease, according to a study of over 1 ...

Research suggests Ozempic could reduce Alzheimer's risk in type 2 diabetes, with a 67% lower diagnosis rate compared to ...

Ozempic and other GLP-1 drugs show promise not only in managing obesity and diabetes but also in reducing Alzheimer's risk. A ...

The University of Cincinnati's Alberto Espay, MD, commented to NBC News on new research published Oct. 24 that found ...

Certain bacteria in the gut might increase the risk of developing Alzheimer's disease, a recent mouse study has found.

Researchers use real-world data in the United States to evaluate the protective role of semaglutide against Alzherimer’s ...

As the popularity of GLP-1 meds like Wegovy and Zepbound grows, fewer Americans are turning to weight-loss surgeries to trim ...

Semaglutide, the active ingredient in Ozempic and Wegovy, may lower the risk of Alzheimer’s disease.A new study suggests type 2 diabetes patients taking semaglu ...

A new study reveals that the active ingredient in drugs like Ozempic and Wegovy could lower the risk of developing ...